Drs. Zeina Nahleh and Maryam Lustberg join the podcast to discuss the updated ASCO guideline on breast cancer follow-up and surveillance after primary treatment. Drs. Nahleh and Lustberg explain the new risk-stratified approach, which personalizes surveillance intensity based on a patient's risk of recurrence, moving away from a one-size-fits-all model. They detail the recommendations for low, intermediate, and high-intensity surveillance groups, review the current role of blood-based biomarkers like ctDNA, and clarify the guideline's stance on supplemental imaging such as MRI and ultrasound. The co-chairs emphasize the importance of shared decision-making between clinicians and patients and discuss how these updated recommendations aim to improve quality of life and reduce unnecessary testing for breast cancer survivors. Read the full guideline, "Breast Cancer Follow-up and Surveillance after Primary Treatment: ASCO Guideline Update," at <a href= "https://www.ascopubs.org/topics/asco-guidelines/breast-cancer" target="_blank" rel= "noopener">www.ascopubs.org/topics/asco-guidelines/breast-cancer</a>" <a href= "ascopubs.org/do/breast-cancer-follow-up-and-surveillance-after-primary-treatment-guideline-update" target="_blank" rel="noopener">LINK TO FULL TRANSCRIPT</a>

Drs. Zeina Nahleh and Maryam Lustberg join the podcast to discuss the updated ASCO guideline on breast cancer follow-up and surveillance after primary treatment. Drs. Nahleh and Lustberg explain the new risk-stratified approach, which personalizes surveillance intensity based on a patient's risk of recurrence, moving away from a one-size-fits-all model. They detail the recommendations for low, intermediate, and high-intensity surveillance groups, review the current role of blood-based biomarkers like ctDNA, and clarify the guideline's stance on supplemental imaging such as MRI and ultrasound. The co-chairs emphasize the importance of shared decision-making between clinicians and patients and discuss how these updated recommendations aim to improve quality of life and reduce unnecessary testing for breast cancer survivors. Read the full guideline, "Breast Cancer Follow-up and Surveillance after Primary Treatment: ASCO Guideline Update," at www.ascopubs.org/topics/asco-guidelines/breast-cancer" LINK TO FULL TRANSCRIPT

Drs. Zeina Nahleh and Maryam Lustberg join the podcast to discuss the updated ASCO guideline on breast cancer follow-up and surveillance after primary treatment. Drs. Nahleh and Lustberg explain the new risk-stratified approach, which personalizes surveillance intensity based on a patient's risk of recurrence, moving away from a one-size-fits-all model. They detail the recommendations for low, intermediate, and high-intensity surveillance groups, review the current role of blood-based biomarkers like ctDNA, and clarify the guideline's stance on supplemental imaging such as MRI and ultrasound. The co-chairs emphasize the importance of shared decision-making between clinicians and patients and discuss how these updated recommendations aim to improve quality of life and reduce unnecessary testing for breast cancer survivors. Read the full guideline, "Breast Cancer Follow-up and Surveillance after Primary Treatment: ASCO Guideline Update," at <a href="https://www.ascopubs.org/topics/asco-guidelines/breast-cancer" rel="noopener noreferrer">www.ascopubs.org/topics/asco-guidelines/breast-cancer</a>" <a href="ascopubs.org/do/breast-cancer-follow-up-and-surveillance-after-primary-treatment-guideline-update" rel="noopener noreferrer">LINK TO FULL TRANSCRIPT</a>

Breast Cancer Follow-Up and Surveillance After Primary Treatment Guideline Update

An interview with Dr. Christopher Flowers of Emory University School of Medicine on the ASCO/IDSA clinical practice guideline which provides updated recommendations on outpatient management of fever and neutropenia in patients with cancer. Read the full guideline at <a href= "http://www.asco.org/supportive-care-guidelines">www.asco.org/supportive-care-guidelines</a>

An interview with Dr. Christopher Flowers of Emory University School of Medicine on the ASCO/IDSA clinical practice guideline which provides updated recommendations on outpatient management of fever and neutropenia in patients with cancer. Read the full guideline at www.asco.org/supportive-care-guidelines

An interview with Dr. Christopher Flowers of Emory University School of Medicine on the ASCO/IDSA clinical practice guideline which provides updated recommendations on outpatient management of fever and neutropenia in patients with cancer. Read the full guideline at <a href="http://www.asco.org/supportive-care-guidelines" rel="noopener noreferrer">www.asco.org/supportive-care-guidelines</a>

Outpatient Management of Fever and Neutropenia Guideline

An interview with Dr. Bryan Schneider of the University of Michigan on the ASCO clinical practice guideline to increase awareness, outline strategies, and offer guidance on the recommended management of immune-related adverse events in patients treated with immune checkpoint inhibitor (ICPi) therapy. Read the full guideline at <a href= "http://www.asco.org/supportive-care-guidelines">www.asco.org/supportive-care-guidelines</a>

An interview with Dr. Bryan Schneider of the University of Michigan on the ASCO clinical practice guideline to increase awareness, outline strategies, and offer guidance on the recommended management of immune-related adverse events in patients treated with immune checkpoint inhibitor (ICPi) therapy. Read the full guideline at www.asco.org/supportive-care-guidelines

An interview with Dr. Bryan Schneider of the University of Michigan on the ASCO clinical practice guideline to increase awareness, outline strategies, and offer guidance on the recommended management of immune-related adverse events in patients treated with immune checkpoint inhibitor (ICPi) therapy. Read the full guideline at <a href="http://www.asco.org/supportive-care-guidelines" rel="noopener noreferrer">www.asco.org/supportive-care-guidelines</a>

Management of Immune-Related Adverse Events Guideline

ASCO Guidelines Podcast breaks down pivotal recommendations from the latest evidence-based clinical practice guidance and provides insight into daily patient care. Listen to stay up to date with the ever-evolving landscape of cancer research and treatment.

Share ASCO Guidelines

Sign up to save your podcasts

ASCO Guidelines

ASCO Guidelines episodes

About ASCO Guidelines

More shows like ASCO Guidelines

NEJM This Week

JAMA Clinical Reviews

Journal of Clinical Oncology (JCO) Podcast

Breast Cancer Update

Gastrointestinal Cancer Update

Research To Practice | Oncology Videos

ASCO Daily News

The Curbsiders Internal Medicine Podcast

Core IM | Internal Medicine Podcast

OncoPharm

ASCO Education

OncLive® On Air

Oncology Today with Dr Neil Love

Two Onc Docs

Oncology Brothers: Practice-Changing Cancer Discussions